Objective: We subjectively and objectively analyzed the clinical effects of underwear for xerotic skin diseases. Methods: We performed a clinical trial for 33 patients aged 20 years or older with xerotic skin diseases visiting the Dermatology Department at Osaka University and Osaka City University Hospital from December 2015 to June 2016 using completely seamless underwear (MediCure
®) distributed by Gunze Limited. We examined the skin manifestations (erythema, nodules, drying, lichenification, and scratching scars), transepidermal water loss (TEWL), and Visual Analogue Scale (VAS) as subjective symptoms of itching and pain, and the Dermatology Life Quality Index (DLQI) on days 0, 14, and 28 after the start of wearing the underwear. Statistical analysis was conducted using the multiple comparison test by Bonferroni and Dunn. Results: Thirty-three patients were registered, including 19 males and 14 females, with an average age of 56.2±18.9. Fifteen cases of atopic dermatitis, 9 cases of asteatotic eczema, 7 cases of psoriasis vulgaris, 6 cases of prurigo nodularis, 4 cases of pruritus, and 1 case of lichenoid amyloidosis were enrolled in this trial. The underlying diseases included 3 cases of renal dysfunction, 3 cases of diabetes, and 2 cases of mental disease. Erythema, xerosis, and scratching scars were significantly improved at day 14 and 28 compared with at day 0. Nodules and lichenification were significantly improved at day 28. TEWL, VAS for itching, and DLQI scores had significantly decreased at day 14 and day 28. No apparent adverse event was observed from the start to the end of the study. Discussion and Conclusion: In this study, all skin lesions were significantly improved, and TEWL, VAS, and DLQI scores significantly decreased. The underwear applied in this trial may improve skin barrier function and symptoms by reducing friction on the skin. Therefore, we suggest advising patients with excess alloknesis to try barrier free underwear for daily skin care.Skin Research, 16: 266-273, 2017
View full abstract